Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
Due to the lack of both prospective trial and high-volume retrospective studies, the management of clinical N+ malignant pleural mesothelioma (MPM) patients remains highly debated. Node positive patients show poor survival compared with node-negative ones; thus, lymph node staging appears crucial in...
Enregistré dans:
Auteurs principaux: | Sara Ricciardi, Francesco Carleo, Massimo O. Jaus, Marco Di Martino, Luigi Carbone, Alberto Ricci, Giuseppe Cardillo |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b19da1ba6c4f479ca290b86230e90ba0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy of Intraoperative Hypertonic Glucose Solution Administration on Persistent Air Leak After Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Retrospective Case–Control Study
par: Alberto Testori, et autres
Publié: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
par: Bonomi M, et autres
Publié: (2017) -
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
par: Giuseppe Mangiameli, et autres
Publié: (2021) -
Serum Calretinin as a Biomarker in Malignant Mesothelioma
par: Cita Zupanc, et autres
Publié: (2021) -
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
par: Hiroto Yoneda, et autres
Publié: (2021)